Acadia Pharmaceuticals | Marktkapitalisierung



Market Capitalization Veränderung Datum
Acadia Pharmaceuticals USD 3.05B 502M 2024-12
ALKERMES USD 4.65B 123M 2024-12
Biogen USD 22.28B 5.95B 2024-12
BioMarin Pharmaceutical USD 12.54B 855M 2024-12
Bristol-Myers Squibb USD 114.71B 9.82B 2024-12
Corcept Therapeutics USD 5.28B 444M 2024-12
Cytokinetics USD 5.55B 661M 2024-12
Eisai JPY 1.26T 322.6B 2024-12
Eli Lilly USD 732.87B 109.15B 2024-12
Incyte USD 13.31B 575M 2024-12
J&J USD 348.19B 41.93B 2024-12
Moderna USD 16B 9.69B 2024-12
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Pfizer USD 150.34B 13.65B 2024-12
Prothena USD 745M 155M 2024-12
PTC Therapeutics USD 3.51B 653M 2024-12
Sarepta Therapeutics USD 11.78B 128M 2024-12
Ultragenyx Pharmaceutical USD 3.88B 1.24B 2024-12
Vertex Pharmaceuticals USD 103.45B 16.4B 2024-12



Acadia Pharmaceuticals Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.